With a significant positively correlation with serum hsCRP levels, AHR transcripts in PBMCs may represent as a novel mediator of the immune disturbance and meta-inflammation in obesity and T2D patients, independent of leptin, the previously-known key metabolic controller and immune modulator (36). The gene discussed is AHR; the disease is obesity disorder.